Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 29, 2026
Approximately 5 minutes
Indonesia Medical Device Registration Timelines in 2025
Indonesia Medical Device Registration Timelines in 2025
1. Overview of the Registration Process
Indonesia’s medical device registration is managed by the Ministry of Health (Kemenkes) through the Directorate General of Pharmaceutical and Medical Devices. All devices require a Distribution Permit (SDAK or Izin Edar Alat Kesehatan) before market entry. Timelines depend on risk classification (A–D per ASEAN MDD), dossier completeness, and authority workload. https://cisema.com/en/indonesia-device-timelines-2025/
2. Risk Classification and Typical Timelines (2025 Estimates)
- Class A (low risk): 3–6 months
Simple devices with minimal documentation; often administrative review only. https://cisema.com/en/indonesia-device-timelines-2025/ - Class B (low-moderate risk): 6–12 months
Moderate documentation; technical review required but usually faster than higher classes. https://cisema.com/en/indonesia-device-timelines-2025/ - Class C (moderate-high risk): 9–18 months
Detailed technical dossier, including clinical data; extended evaluation periods common. https://cisema.com/en/indonesia-device-timelines-2025/ - Class D (high risk): 18–24+ months
Comprehensive technical and clinical evaluation; frequent requests for additional information or clarifications. https://cisema.com/en/indonesia-device-timelines-2025/
These are indicative timelines and may be longer due to backlog, incomplete submissions, or complex products.
3. Factors Influencing Timelines
Several elements can extend or shorten the process:
- Dossier quality — Complete, well-organized submissions using ASEAN CSDT format reduce delays.
- Local agent efficiency — Prompt responses to authority queries accelerate progress.
- Product complexity — Implantables, software as medical device (SaMD), or combination products often face longer reviews.
- Regulatory changes — 2025 updates to e-registration systems or post-market requirements may impact processing times.
- Peak periods — Year-end or post-holiday backlogs can add 2–4 months. https://cisema.com/en/indonesia-device-timelines-2025/
4. Expedited Pathways
- ASEAN reliance — Devices with marketing approval in reference ASEAN countries may qualify for faster review via CSDT pathway.
- Priority products — Certain essential or innovative devices (e.g., during public health emergencies) can receive expedited handling.
- Pre-submission consultation — Early dialogue with authorities can help avoid major deficiencies and shorten overall timelines. https://cisema.com/en/indonesia-device-timelines-2025/
5. Post-Registration Considerations
After permit issuance:
- Validity is typically 5 years (renewal required).
- Annual post-market surveillance reporting is mandatory.
- Changes to device or labeling require variation applications, which may take 3–12 months depending on scope. https://cisema.com/en/indonesia-device-timelines-2025/
Accurate planning, strong local support, and high-quality submissions remain key to achieving registration within expected 2025 timelines in Indonesia’s evolving regulatory environment. https://cisema.com/en/indonesia-device-timelines-2025/
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Indonesia Medical Device Registration Process Overview
Andaman Medical outlines the key steps and requirements for registering medical devices in Indonesia, including classification, local agent appointment, technical documentation submission, evaluation by the Indonesian Ministry of Health, and issuance of distribution permits under the current regulatory framework managed by BPOM and the Directorate General of Pharmaceutical and Medical Devices.
Approximately 5 minutes
Indonesia Medical Device Registration Process Overview
Andaman Medical outlines the key steps and requirements for registering medical devices in Indonesia, including classification, local agent appointment, technical documentation submission, evaluation by the Indonesian Ministry of Health, and issuance of distribution permits under the current regulatory framework managed by BPOM and the Directorate General of Pharmaceutical and Medical Devices.